Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Am J Cardiol. 2018 Nov 6;123(3):466–473. doi: 10.1016/j.amjcard.2018.10.027

Table 4:

Echocardio-Doppler parameters of the cohort stratified based on fibrosis stage.

Echocardio-Doppler parameters Overall Group Stage 0 Stage 1 Stage 2 Stage 3 P-value
LVEF(%) 55
(52–58)		 58
(53–58)		 55
(53–62)		 60
(53–64)		 54
(52–57)		 0.21
E/A 0.95
(0.86–1.1)		 1.07
(1.00–1.15)		 0.96
(0.88–1.03)		 0.99
(0.88–1.10)		 0.87
(0.80–1.22)		 0.10
Rest E/e’ 7.5
(5.9–9.4)		 7.6
(5.7–8.3)		 7.0
(6.0–8.1)		 7.4
(6.2–10.7)		 11.1
(5.7–16.3)		 0.21
Stress e’ (cm/s) 13.0
(10.9–14.9)		 14.0
(12.4–17.7)		 13.6
(11.1–16.0)		 11.6
(6.6–14.6)		 11.6
(8.6–13.1)		 0.06
Stress E/e’ 6.9
(5.6–10.2)		 5.6
(4.8–7.4)		 6.5
(5.2–8.6)		 8.7
(6.0–12.8)		 9.8
(6.6–19.6)		 0.01

Abbreviations: LVEF=left-ventricular ejection fraction; E/A=ratio of peak early (E) velocity flow to late (A) peak velocity flow in diastole; E/e’= ratio of early transmitral E wave velocity (E) to early mitral annulus velocities (e’) by tissue Doppler averaged between the lateral and septal.